The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study

OBJECTIVE: Intrahepatic cholangiocarcinoma (iCCA) is a primary liver malignancy with a poor prognosis and limited treatment. Cisplatin with gemcitabine is used as the standard first-line chemotherapy regimen; however, there is still no robust evidence for second-line and successive treatments. Altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Peixin, Huang, Xiaoyong, Zhou, Yingting, Yang, Guohuan, Sun, Qiman, Shi, Guoming, Chen, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529477/
https://www.ncbi.nlm.nih.gov/pubmed/36199981
http://dx.doi.org/10.1155/2022/9680933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529477/
https://www.ncbi.nlm.nih.gov/pubmed/36199981
http://dx.doi.org/10.1155/2022/9680933

Ejemplares similares